Spots Global Cancer Trial Database for cd28
Every month we try and update this database with for cd28 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) | NCT01853631 | Non-Hodgkin Lym... Chronic Lymphoc... Acute Lymphocyt... | Dose Escalation... Expansion Phase... | - 75 Years | Baylor College of Medicine | |
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | NCT04223765 | Mantle Cell Lym... Follicular Lymp... Splenic Margina... Extranodal Marg... Nodal Marginal ... Indolent Non-ho... | CAR.k.28 Fludarabine Cyclophosphamid... Bendamustine | 18 Years - | UNC Lineberger Comprehensive Cancer Center |